Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDR | P35968 | 6/20 | 0.57 |
| ▸ | MAPT | P10636 | 2/20 | 0.50 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.50 |
| ▸ | JAK1 | P23458 | 2/20 | 0.50 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.50 |
| ▸ | JAK2 | O60674 | 3/20 | 0.49 |
| ▸ | LMNA | P02545 | 2/20 | 0.48 |
| ▸ | NAMPT | P43490 | 2/20 | 0.48 |
| ▸ | NPC1 | O15118 | 1/20 | 0.48 |
| ▸ | TSHR | P16473 | 1/20 | 0.48 |
| ▸ | TYK2 | P29597 | 2/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.47 |
| ▸ | NT5E | P21589 | 1/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27467102 | 0.89 | SMN1; SMN2 (0.54) | KDRMAPTSMN1; SMN2MAPK1LMNA | |
| SCHEMBL27486254 | 0.89 | SMN1; SMN2 (0.53) | KDRMAPTSMN1; SMN2JAK1JAK2 | |
| SCHEMBL27548625 | 0.88 | KDR (0.59) | KDRMAPTSMN1; SMN2JAK1NAMPT | |
| SCHEMBL27609433 | 0.88 | ALDH1A1 (0.52) | KDRMAPTSMN1; SMN2JAK1JAK2 | |
| SCHEMBL27465576 | 0.86 | JAK2 (0.52) | KDRMAPTJAK1MAPK1JAK2 | |
| SCHEMBL27485248 | 0.84 | KDR (0.59) | KDRMAPTSMN1; SMN2MAPK1LMNA | |
| SCHEMBL27484906 | 0.83 | JAK2 (0.52) | KDRSMN1; SMN2JAK1MAPK1JAK2 | |
| SCHEMBL27485244 | 0.83 | ALDH1A1 (0.52) | KDRMAPTSMN1; SMN2MAPK1LMNA | |
| SCHEMBL27486252 | 0.83 | KDR (0.48) | KDRMAPTSMN1; SMN2JAK1MAPK1 | |
| SCHEMBL27468045 | 0.82 | KDR (0.44) | KDRMAPTSMN1; SMN2JAK1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-1152014-C | N-aryl (thio) anthranilic acid amide derivatives, their prepn. and their use as VEGF receptor tyrosine kinase inhibitors | ��˹��ŵ�� | 2004-06-02 | — | — | CN | claimed |
| CN-1331680-A | N-aryl (thio) anthranilic acid amide derivatives, their prepn. and their use as VEGF receptor tyrosine kinase inhibitors | NOVARTIS AG (CH) | 2002-01-16 | — | — | CN | claimed |
| CN-1152014-C | N-aryl (thio) anthranilic acid amide derivatives, their prepn. and their use as VEGF receptor tyrosine kinase inhibitors | ��˹��ŵ�� | 2004-06-02 | — | — | CN | disclosed |
| CN-1331680-A | N-aryl (thio) anthranilic acid amide derivatives, their prepn. and their use as VEGF receptor tyrosine kinase inhibitors | NOVARTIS AG (CH) | 2002-01-16 | — | — | CN | disclosed |